Présentation
- Docteur en Pharmacologie de l'Université Sorbonne Paris Nord.
- Expériences d'enseignement au sein de plusieurs facultés de Santé (déprtements de médecine et de pharmacie) : Université Sétif 1 et Université d'Angers.
- Qualifié par le ministère de l'Enseignement Supérieur français au rang de Maître de Conférences des Universités (MCU).
- Titulaire d'une habilitation à diriger des recherches (HDR).
- Chercheur et auteur de nombreux articles scientifiques de renom.
- Ancien chercheur à l'hôpital universitaire de l'Utah (Etats-Unis).
Liste des publications
- Biologie cellulaire (Livre), 2023 ISBN : 978-2-487-14800-0.
- Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches. J. Clin. Medicine. 2021;10(17):3803.
- Type 2 diabetes and physical activity: A focus on cell-to-cell communication and pharmacology. Fundamental Clinical Pharmacology, 2021; 35(5):808-821.
- Decreased vasorelaxation induced by iloprost during acute inflammation in human internal mammary artery. European Journal of Pharmacology. 2017; 804: 31-37
- Asthma causes inflammation of human pulmonary arteries and decreases vasodilatation induced by prostaglandin. Journal of Asthma, 2017; 21: 1-7
- Stratégies actuelles de lutte contre la résistance aux antibiotiques. Journal des anti-infectieux. 2017; 19 :12-9
- The role of prostaglandin E2 in human vascular inflammation. Prostaglandins, Leukotrienes & Essential Fatty Acids, 2013; 89:55-63
- Prostaglandin E2 receptor subtypes in human blood and vascular cells. European Journal of Pharmacology. 2012; 695:1-6
- Prostaglandin E2 induced contraction of human intercostal arteries is mediated by the EP3 receptor. European Journal of Pharmacology. 2012; 681:55-9
- Differential reactivity of human mammary artery and saphenous vein to prostaglandin E2 British Journal of Pharmacology. 2011; 163: 826-34
- Involvement of prostaglandin F2α in preeclamptic human umbilical vein vasospasm: a role of prostaglandin F. Journal of Hypertension. 2010; 28: 2438-45
- Increased human vascular reactivity via cyclooxygenase-2 inhibition during acute inflammation: Role of Prostaglandins E2 and I2. Inflammation Research 2009; 58, S249–S251
- Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits. Am J Physiol - Heart and Circulatory Physiology 2009; 297:H1882-8
- Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine. Cardiovascular Research. 2009; 81:269-77
- Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. British Journal of Pharmacology. 2008; 154: 1631-9
- A new mrna splice variant coding for the human EP3-I. • Prostaglandins Leukot Essent Fatty Acids. 2007; 77: 195-201
- Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma. Arterioscler. Thromb. Vasc. Biol. 2007; 27: 525-31.
Prix scientifiques
- Prix de la recherche 2010, Université Sétif 1
- Young Investigator Award, World Congress on Inflammation 2009, Tokyo
- Prix de thèse 2009 de l’association GREMI, Institut Pasteur, Paris
Contact
Email : nabil@foudi.com